1 unchanged sentence
Insider Trading Plans
−Removed: During the quarter ended September
−Removed: 30, 2025, no director or Section 16 officer adopted , modified, or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule
−Removed: 10b5-1 trading arrangement” (in each case, as defined in Item 408(a) of Regulation S-K).
+Added: During the quarter ended December 31, 2025, no director
+Added: or Section 16 officer adopted , modified, or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading
+Added: arrangement” (in each case, as defined in Item 408(a) of Regulation S-K) .
Exhibits required by Item 601 of Regulation S-K:
5 unchanged sentences
(incorporated by reference to Exhibit 10.2 to the Company’s Form 10-Q filed with the SEC on February 19, 2025)
−Removed: of Exchange Agreement (incorporated herein by reference to Exhibit 99.1 to Form 8-K filed with the SEC on July 9, 2025)
+Added: Form of Exchange Agreement (incorporated herein by reference to Exhibit 99.1 to Form 8-K filed with the SEC on July 9, 2025)
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
14 unchanged sentences
undersigned, thereunto duly authorized.
−Removed: November 14, 2025
+Added: February 17, 2026
LUNAI BIOWORKS INC.
8 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.